Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Kamakoli, Mansour Kargarpour ^a   Sadegh, Hamid Reza ^a   Farmanfarmaei, Ghazaleh ^a   Masoumi, Morteza ^b   Fateh, Abolfazl ^b   Javadi, Gholamreza ^a   Rahimi Jamnani, Fatemeh ^b   Vaziri, Farzam ^b   Siadat, Seyed Davar ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLOW UP; GENETICS; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; VARIABLE NUMBER OF TANDEM REPEAT;

FOLLOW-UP STUDIES; HUMANS; MINISATELLITE REPEATS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 85010960665     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41410     Document Type: Article

References (20)

1. Chindelevitch, L., Colijn, C., Moodley, P., Wilson, D. & Cohen, T. ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections. PLoS.Comput Biol. 12(2), e1004475 (2016).
2. Streit, E., Millet, J. & Rastogi, N. Mycobacterium tuberculosis polyclonal infections and microevolution identified by MIRU-VNTRs in an epidemiological study. Int. J Mycobacteriol. 4(3), 222-7 (2015).
3. Mulenga, C. et al. Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia. BMC Infect. Dis. 10(1), 1 (2010).
4. Cohen, T., Wilson, D., Wallengren, K., Samuel, E. Y. & Murray, M. Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. J Clin. Microbiol. 49, 385-8 (2011).
5. Cohen, T. et al. Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin. Microbiol. Rev. 25, 708-19 (2012).
6. Kumar, P. et al. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. Tuberculosis 94(1), 73-80 (2014).
7. Chatterjee, A. & Mistry, N. MIRU-VNTR profiles of three major Mycobacterium tuberculosis spoligotypes found in western India. Tuberculosis 93(2), 250-6 (2013).
8. Bidovec-Stojkovič, U., Seme, K., Žolnir-Dovč, M. & Supply, P. Prospective genotyping of Mycobacterium tuberculosis from fresh clinical samples. PloS One 9(10), e109547 (2014).
9. Alonso, M. et al. Real-Time molecular epidemiology of tuberculosis by direct genotyping of smear-positive clinical specimens. J Clin. Microbiol. 50, 1755-7 (2012).
10. Hajimiri, E. S. et al. High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country. Microb. Pathog. 93, 213-8 (2016).
11. Zheng, C. et al. Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates. J Clin. Microbiol. 53(7), 2138-47 (2015).
12. Zetola, N. M. et al. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol 52(7), 2422-9 (2014).
13. Hofmann-Thiel, S. et al. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur. Respir. J 33, 368-374 (2009).
14. Zetola, N. M. et al. Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests. J Infect. Dis. 209, 1754-63 (2014).
15. Cohen, T. et al. Within-Host Heterogeneity of Mycobacterium tuberculosis Infection Is Associated With Poor Early Treatment Response: A Prospective Cohort Study. J Infect. Dis. 213(11), 1796-9 (2016).
16. Hingley-Wilson, S. M. et al. Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg. Infect. Dis. 19(7), 1138-41 (2013).
17. Behr, M. A. Tuberculosis due to multiple strains: A concern for the patient? A concern for tuberculosis control? Am. J Respir. Crit. Care Med. 169(5), 554-5 (2004).
18. Hu, Y. et al. Drug resistance characteristics and cluster analysis of M.Tuberculosis in Chinese patients with multiple episodes of antituberculosis treatment. BMC Infect. Dis. 16, 4, doi: 10.1186/s12879-015-1331-z (2016).
19. Merker, M. et al. Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS One 8(12), e82551 (2013).
20. Supply, P. et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin. Microbiol. 44(12), 4498-510 (2006).